176 related articles for article (PubMed ID: 33022448)
1. Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
Cordeiro Mitchell CN; Hunkler KF; Maher JY; Garbose RA; Gornet ME; Whiting-Collins LJ; Christianson MS
J Gynecol Obstet Hum Reprod; 2021 May; 50(5):101930. PubMed ID: 33022448
[TBL] [Abstract][Full Text] [Related]
2. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
Falcone F; Laurelli G; Losito S; Di Napoli M; Granata V; Greggi S
J Gynecol Oncol; 2017 Jan; 28(1):e2. PubMed ID: 27670256
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel-releasing intrauterine device therapy vs oral progestin treatment for reproductive-aged patients with endometrial intraepithelial neoplasia: a systematic review and meta-analysis.
Suzuki Y; Ferris JS; Chen L; Dioun S; Usseglio J; Matsuo K; Xu X; Hershman DL; Wright JD
J Natl Cancer Inst; 2024 May; 116(5):653-664. PubMed ID: 38305500
[TBL] [Abstract][Full Text] [Related]
4. Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta-analysis.
De Rocco S; Buca D; Oronzii L; Petrillo M; Fanfani F; Nappi L; Liberati M; D'Antonio F; Scambia G; Leombroni M; Dessole M; Lucidi A
Eur J Obstet Gynecol Reprod Biol; 2022 Jun; 273():90-97. PubMed ID: 35526471
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol.
Zhao X; Niu J; Shi C; Liu Z
Reprod Health; 2022 Nov; 19(1):206. PubMed ID: 36333773
[TBL] [Abstract][Full Text] [Related]
6. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia.
Marnach ML; Butler KA; Henry MR; Hutz CE; Langstraat CL; Lohse CM; Casey PM
J Womens Health (Larchmt); 2017 Apr; 26(4):368-373. PubMed ID: 27901412
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation in early-stage endometrial cancer and endometrial intraepithelial neoplasia: A single-center experience.
Ayhan A; Tohma YA; Tunc M
Taiwan J Obstet Gynecol; 2020 May; 59(3):415-419. PubMed ID: 32416890
[TBL] [Abstract][Full Text] [Related]
8. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
Hahn HS; Yoon SG; Hong JS; Hong SR; Park SJ; Lim JY; Kwon YS; Lee IH; Lim KT; Lee KH; Shim JU; Mok JE; Kim TJ
Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
[TBL] [Abstract][Full Text] [Related]
9. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.
Herrera Cappelletti E; Humann J; Torrejón R; Gambadauro P
Hum Reprod Update; 2022 Feb; 28(2):282-295. PubMed ID: 34935045
[TBL] [Abstract][Full Text] [Related]
10. Dilatation and curettage is more accurate than endometrial aspiration biopsy in early-stage endometrial cancer patients treated with high dose oral progestin and levonorgestrel intrauterine system.
Kim DH; Seong SJ; Kim MK; Bae HS; Kim M; Yun BS; Jung YW; Shim JY
J Gynecol Oncol; 2017 Jan; 28(1):e1. PubMed ID: 27670255
[TBL] [Abstract][Full Text] [Related]
11. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis.
Fan Z; Li H; Hu R; Liu Y; Liu X; Gu L
Int J Gynecol Cancer; 2018 Feb; 28(2):385-393. PubMed ID: 29266019
[TBL] [Abstract][Full Text] [Related]
12. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
[TBL] [Abstract][Full Text] [Related]
13. Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia.
Suzuki Y; Chen L; Hou JY; St Clair CM; Khoury-Collado F; de Meritens AB; Matsuo K; Melamed A; Hershman DL; Wright JD
Obstet Gynecol; 2023 May; 141(5):979-987. PubMed ID: 37023446
[TBL] [Abstract][Full Text] [Related]
14. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
Novikova OV; Nosov VB; Panov VA; Novikova EG; Krasnopolskaya KV; Andreeva YY; Shevchuk AS
Gynecol Oncol; 2021 Apr; 161(1):152-159. PubMed ID: 33461741
[TBL] [Abstract][Full Text] [Related]
15. The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth rates.
Acosta-Torres S; Murdock T; Matsuno R; Beavis AL; Stone RL; Wethington SL; Levinson K; Grumbine F; Ferriss JS; Tanner EJ; Fader AN
Gynecol Oncol; 2020 May; 157(2):348-356. PubMed ID: 32085863
[TBL] [Abstract][Full Text] [Related]
16. A survey of French gynecologists' knowledge and attitudes toward conservative treatment for fertility preservation in young patients with endometrial cancer.
Peigné M; Maumy L; Koskas M
J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101794. PubMed ID: 32416273
[TBL] [Abstract][Full Text] [Related]
17. Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review.
Murakami I; Machida H; Morisada T; Terao Y; Tabata T; Mikami M; Hirashima Y; Kobayashi Y; Baba T; Nagase S
J Gynecol Oncol; 2023 Jul; 34(4):e49. PubMed ID: 36929578
[TBL] [Abstract][Full Text] [Related]
18. Fertility-preserving treatment in patients with early-stage endometrial cancer: A protocol for systematic review and meta-analysis.
Zhao XL; Du ZQ; Zhang X; Yao Z; Liang YQ; Zhao SF
Medicine (Baltimore); 2021 Dec; 100(48):e27961. PubMed ID: 35049199
[TBL] [Abstract][Full Text] [Related]
19. Should progesterone and estrogen receptors be assessed for predicting the response to conservative treatment of endometrial hyperplasia and cancer? A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Aug; 98(8):976-987. PubMed ID: 30779338
[TBL] [Abstract][Full Text] [Related]
20. Conservative management of endometrial cancer: a survey amongst European clinicians.
La Russa M; Zapardiel I; Halaska MJ; Zalewski K; Laky R; Dursun P; Lindquist D; Sukhin V; Polterauer S; Biliatis I
Arch Gynecol Obstet; 2018 Aug; 298(2):373-380. PubMed ID: 29943129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
